共 119 条
[1]
Darby S(2011)Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10801 women in 17 randomised trials Lancet 378 1707-1716
[2]
McGale P(2013)The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials Lancet Oncol 14 1086-1094
[3]
Correa C(2010)Long-term results of hypofractionated radiation therapy for breast cancer N Engl J Med 362 513-520
[4]
Taylor C(2009)Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial J Clin Oncol 27 4939-4947
[5]
Arriagada R(2008)The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial Lancet Oncol 9 331-341
[6]
Haviland JS(2008)The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial Lancet Oncol 4 331-341
[7]
Owen JR(2005)Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial Radiother Oncol 75 9-17
[8]
Dewar JA(2018)Radiation therapy for the whole breast: executive summary of an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline Pract Radiat Oncol 8 145-152
[9]
Agrawal KR(2021)Comparing hypofractionated with conventional fractionated radiotherapy after breast-conserving surgery for early breast cancer a meta-analysis of randomized controlled trials Front Oncol 11 753209-56
[10]
Barrett J(2015)European organisation for research and treatment of cancer radiation oncology and breast cancer groups whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer Lancet Oncol 16 47-2598